As unregulated peptides grow in popularity, doctors warn of unknown risks ABC7 San Francisco Indictment of Osteopathic Physician Signals Shift in Peptide Enforcement Stevens & Lee The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea Know Your Source: Protecting Patients from Unsafe Drugs FDA Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law